Phase III clinical trial - Gynécologie - Col utérus

Gynécologie - Col utérus
Ouvert depuis le: 09.18.2021
Site: Paris
Ouvert depuis le: 11.26.2019
Site: Saint-Cloud
Public cible
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
Description de l'essai

SENTICOL III is large prospective multicenter international randomized study designed to validate the Sentinel Lymph Node (SLN) mapping technique in early cervical cancer. This "validation study" will compare the outcome of patients with negative SLN (experimental arm) vs patients with negative SLN + Pelvic Lymph Node dissection (PLN)(reference arm).